回盛生物(300871.SZ)：公司及控股子公司拟合计转让武汉盛宠80%股权

Core Viewpoint - The company is expanding its online sales channels for pet pharmaceuticals by transferring 80% of its stake in Wuhan Shengchong Technology Co., Ltd. to Wuhan Xingzhishang Technology Partnership (Limited Partnership) for a total price of RMB 5.52 million [1] Group 1 - The transaction involves Wuhan Kaisheng Biological Technology Co., Ltd. and its subsidiary Wuhan Petry Biological Technology Co., Ltd. [1] - The board of directors has authorized the management to handle all matters related to this transaction, including negotiation, execution, signing of contracts, and business registration changes [1]